Glen Eagle Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-375
Closed -$5.92K 945
2021
Q3
$5.92K Hold
375
﹤0.01% 795
2021
Q2
$8.1K Hold
375
﹤0.01% 730
2021
Q1
$7.6K Hold
375
﹤0.01% 706
2020
Q4
$6.71K Hold
375
﹤0.01% 695
2020
Q3
$4.36K Hold
375
﹤0.01% 710
2020
Q2
$3.46K Hold
375
﹤0.01% 709
2020
Q1
$3.9K Hold
375
﹤0.01% 654
2019
Q4
$6.71K Buy
+375
New +$5.54K ﹤0.01% 666

Other funds holding AXGN

Glen Eagle Advisors's AXGN Position: Q4 2021 in Review

Glen Eagle Advisors sold out of Axogen (AXGN) in Q4 2021, closing a stake of 375 shares — an estimated $5.92K sold.

Glen Eagle Advisors first reported a position in AXGN in Q4 2019 and held it in 8 quarters. The position peaked at $8.1K in Q2 2021. 134 funds tracked by Wall St. Rank hold AXGN as of Q4 2021.

  • Glen Eagle Advisors reported no remaining Axogen position as of Q4 2021 after selling out during the quarter.
  • Glen Eagle Advisors sold 375 Axogen shares in Q4 2021, an estimated $5.92K.
  • Glen Eagle Advisors first reported a position in Axogen in Q4 2019 and held it in 8 quarters.
  • Glen Eagle Advisors's Axogen position peaked at $8.1K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Axogen as of Q4 2021.

Based on Glen Eagle Advisors's 13F filing for Q4 2021, filed 13 Aug 2024.